204 related articles for article (PubMed ID: 23709681)
1. Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.
Wu T; Young JS; Johnston H; Ni X; Deng R; Racine J; Wang M; Wang A; Todorov I; Wang J; Zeng D
J Immunol; 2013 Jul; 191(1):488-99. PubMed ID: 23709681
[TBL] [Abstract][Full Text] [Related]
2. T cells, murine chronic graft-versus-host disease and autoimmunity.
Eisenberg RA; Via CS
J Autoimmun; 2012 Sep; 39(3):240-7. PubMed ID: 22704961
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 regulates CD4
Tsai JJ; Velardi E; Shono Y; Argyropoulos KV; Holland AM; Smith OM; Yim NL; Rao UK; Kreines FM; Lieberman SR; Young LF; Lazrak A; Youssef S; Fu YY; Liu C; Lezcano C; Murphy GF; Na IK; Jenq RR; Hanash AM; Dudakov JA; van den Brink MRM
Blood; 2018 Dec; 132(26):2763-2774. PubMed ID: 30381375
[TBL] [Abstract][Full Text] [Related]
4. Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease.
Lockridge JL; Zhou Y; Becker YA; Ma S; Kenney SC; Hematti P; Capitini CM; Burlingham WJ; Gendron-Fitzpatrick A; Gumperz JE
Biol Blood Marrow Transplant; 2013 Sep; 19(9):1310-22. PubMed ID: 23806772
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin inhibition rescues alloantigen-specific central memory T cell subsets that promote chronic GVHD.
Wang Y; Ullah MA; Waltner OG; Bhise SS; Ensbey KS; Schmidt CR; Legg SR; Sekiguchi T; Nelson EL; Kuns RD; Nemychenkov NS; Atilla E; Yeh AC; Takahashi S; Boiko JR; Varelias A; Blazar BR; Koyama M; Minnie SA; Clouston AD; Furlan SN; Zhang P; Hill GR
J Clin Invest; 2024 Jun; 134(11):. PubMed ID: 38828727
[TBL] [Abstract][Full Text] [Related]
6. CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice.
Adams RC; Carter-Cusack D; Llanes GT; Hunter CR; Vinnakota JM; Ruitenberg MJ; Vukovic J; Bertolino P; Chand KK; Wixey JA; Nayler SP; Hill GR; Furlan SN; Zeiser R; MacDonald KPA
Blood; 2024 Mar; 143(10):912-929. PubMed ID: 38048572
[TBL] [Abstract][Full Text] [Related]
7. CD8
Patel SJ; Yokoyama WM
J Immunol; 2017 Nov; 199(9):3212-3221. PubMed ID: 28972091
[TBL] [Abstract][Full Text] [Related]
8. A Novel Murine Model for Lupus-Like Ocular Chronic Graft-Versus-Host Disease.
Sun Y; Zhang Y; Shen J; Shi F; Li Y; Wang C; Dong X; Chen T; Yu F; Zhou Y; Wan P
Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):20. PubMed ID: 38864812
[TBL] [Abstract][Full Text] [Related]
9. Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice.
Adams RC; Carter-Cusack D; Shaikh SN; Llanes GT; Johnston RL; Quaife-Ryan G; Boyle G; Koufariotis LT; Möller A; Blazar BR; Vukovic J; MacDonald KPA
Blood; 2022 Mar; 139(9):1389-1408. PubMed ID: 34570880
[TBL] [Abstract][Full Text] [Related]
10. Unique patterns of CD8+ T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease.
Érsek B; Lupsa N; Pócza P; Tóth A; Horváth A; Molnár V; Bagita B; Bencsik A; Hegyesi H; Matolcsy A; Buzás EI; Pós Z
Cell Mol Life Sci; 2016 Oct; 73(20):3935-47. PubMed ID: 27137185
[TBL] [Abstract][Full Text] [Related]
11. Positive Effects of Oral Antibiotic Administration in Murine Chronic Graft-Versus-Host Disease.
Sato S; Shimizu E; He J; Ogawa M; Asai K; Yazu H; Rusch R; Yamane M; Yang F; Fukuda S; Kawakami Y; Tsubota K; Ogawa Y
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916809
[TBL] [Abstract][Full Text] [Related]
12. Immunohistopathology of oral mucosal chronic graft-versus-host disease severity and duration.
Tollemar V; Ström J; Tudzarovski N; Häbel H; Legert KG; Heymann R; Warfvinge G; Le Blanc K; Sugars RV
Oral Dis; 2023 Nov; 29(8):3346-3359. PubMed ID: 35796584
[TBL] [Abstract][Full Text] [Related]
13. Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.
Knorr DA; Wang H; Aurora M; MacMillan ML; Holtan SG; Bergerson R; Cao Q; Weisdorf DJ; Cooley S; Brunstein C; Miller JS; Wagner JE; Blazar BR; Verneris MR
Biol Blood Marrow Transplant; 2016 May; 22(5):825-33. PubMed ID: 26806586
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-host disease: role of inflammation in the development of chromosomal abnormalities of keratinocytes.
Sloand EM; Pfannes L; Ling C; Feng X; Jasek M; Calado R; Tucker ZC; Hematti P; Maciejewski J; Dunbar C; Barrett J; Young N
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1665-73. PubMed ID: 20659573
[TBL] [Abstract][Full Text] [Related]
15. Trafficking between clonally related peripheral T-helper cells and tissue-resident T-helper cells in chronic GVHD.
Kong X; Wu X; Wang B; Zeng D; Cassady K; Nasri U; Zheng M; Wu A; Qin H; Tsai W; Salhotra A; Nakamura R; Martin PJ; Zeng D
Blood; 2022 Dec; 140(25):2740-2753. PubMed ID: 36084473
[TBL] [Abstract][Full Text] [Related]
16. Cellular senescence promotes meibomian gland dysfunction in a chronic graft-versus-host disease mouse model.
Sato S; Ogawa Y; Shimizu E; Asai K; Okazaki T; Rusch R; Hirayama M; Shimmura S; Negishi K; Tsubota K
Ocul Surf; 2024 Apr; 32():198-210. PubMed ID: 38499288
[TBL] [Abstract][Full Text] [Related]
17. Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15.
Liu C; Lan Q; Cao S; Zheng F; Liang Y; Shen J; Wang Y; Ikezoe T; Xu K; Pan B
Leukemia; 2024 Jun; 38(6):1390-1402. PubMed ID: 38459169
[TBL] [Abstract][Full Text] [Related]
18. Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic graft-versus-host disease: A pilot study.
Motta A; Zhan Q; Larson A; Lerman M; Woo SB; Soiffer RJ; Murphy GF; Treister NS
Oral Dis; 2018 May; 24(4):580-590. PubMed ID: 29197137
[TBL] [Abstract][Full Text] [Related]
19. BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes.
Zaiken MC; Flynn R; Paz KG; Rhee SY; Jin S; Mohamed FA; Saha A; Thangavelu G; Park PMC; Hemming ML; Sage PT; Sharpe AH; DuPage M; Bluestone JA; Panoskaltsis-Mortari A; Cutler CS; Koreth J; Antin JH; Soiffer RJ; Ritz J; Luznik L; Maillard I; Hill GR; MacDonald KPA; Munn DH; Serody JS; Murphy WJ; Kean LS; Zhang Y; Bradner JE; Qi J; Blazar BR
Blood; 2022 May; 139(19):2983-2997. PubMed ID: 35226736
[TBL] [Abstract][Full Text] [Related]
20. Embigin Is Highly Expressed on CD4+ and CD8+ T Cells but Is Dispensable for Several T Cell Effector Responses.
Yang H; Iwanaga N; Katz AR; Ridley AR; Miller HD; Allen MJ; Pociask D; Kolls JK
Immunohorizons; 2024 Mar; 8(3):242-253. PubMed ID: 38446446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
